Relation between chemosensitivity and the ventilatory response to exercise in chronic heart failure

Journal of the American College of Cardiology

Volumn 27, Issue 3, 1996, Pages 650-657

  Chua, Tuan Peng ^a   Clark, Andrew L ^a   Amadi, Aham A ^a   Coats, Andrew J S ^a  

^a NATIONAL HEART AND LUNG INSTITUTE   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ARTICLE; CHEMOSENSITIVITY; CLINICAL ARTICLE; CONTROLLED STUDY; EXERCISE; FEMALE; HEART FAILURE; HEART LEFT VENTRICLE EJECTION FRACTION; HUMAN; HYPERCAPNIA; MALE; OXYGEN CONSUMPTION; PATHOPHYSIOLOGY; PRIORITY JOURNAL; RESPIRATORY FUNCTION;

EID: 0029971287     PISSN: 07351097     EISSN: None     Source Type: Journal    
DOI: 10.1016/0735-1097(95)00523-4     Document Type: Article

References (57)

1. Cohn JN, Archibald DG, Ziesche S, et al. Effect of vasodilator therapy on mortality in chronic congestive heart failure. Results of a Veterans Administration cooperative study. N Engl J Med 1986;314:1547-52.
2. CONSENSUS Trial Study Group. Effects of enalapril on mortality in severe congestive heart failure. Results of the cooperative north Scandinavian enalapril survival study (CONSENSUS). N Engl J Med 1987;316:1429-35.
3. SOLVD Investigators. Effect of enalapril on survival in patients with reduced left ventricular ejection fractions and congestive heart failure. N Engl J Med 1991;325:293-302.
4. Cohn JN, Johnson G, Ziesche S, et al. A comparison of enalapril with hydralazine-isosorbide dinitrate in the treatment of chronic congestive heart failure. N Engl J Med 1991;325:303-10.
5. Clark AL, Coats AJS. The mechanisms underlying the increased ventilatory response to exercise in chronic heart failure. Eur Heart J 1992;13:1698-708.
6. Wilson JR, Mancini DM. Factors contributing to the exercise limitation of heart failure. J Am Coll Cardiol 1993;22(Suppl A):93A-8A.
7. Franciosa JA, Park M, Levine TB. Lack of correlation between exercise capacity and indexes of resting left ventricular performance in heart failure. Am J Cardiol 1981;47:33-9.
8. Higginbotham MB, Morris KG, Conn EH, Coleman RE, Cobb FR. Determinants of variable exercise performance among patients with severe left ventricular dysfunction. Am J Cardiol 1983;51:52-60.
9. Kraemer MD, Kubo SH, Rector TS, Brunsvold N, Bank AJ. Pulmonary and peripheral vascular factors are important determinants of peak exercise oxygen uptake in patients with heart failure. J Am Coll Cardiol 1993;21: 641-8.
10. Massie BM, Conway M, Yonge R, Frostick S, Ledingham J. Skeletal muscle metabolism during exercise under ischaemic conditions in congestive cardiac failure. Circulation 1988;78:320-6.
11. Minotti JR, Christoph I, Oka R, Weiner MW, Wells L, Massie BM. Impaired skeletal muscle function in patients with congestive heart failure. Relationship to systemic exercise performance. J Clin Invest 1991;88:2077-82.
12. Wilson JR, Mancini DM, Dunkman WR. Exertional fatigue due to skeletal muscle dysfunction in patients with heart failure. Circulation 1993;87:470-5.
13. Levine TB, Levine AB. Regional blood flow supply and demand in heart failure. Am Heart J 1990;120:1547-51.
14. Weber KT, Kinasewitz GT, Janicki JS, Fishman AP. Oxygen utilization and ventilation during exercise in patients with chronic cardiac failure. Circulation 1982;65:1213-23.
15. Buller NP, Poole-Wilson PA. Mechanisms of increased ventilatory responses to exercise in patients with chronic heart failure. Br Heart J 1990;63:281-3.
16. 2 rebreathing in normal subjects. Clin Sci 1972;43:861-7.
17. Martin BJ, Weil JV, Sparks KE, McCullough RE, Grover RF. Exercise ventilation correlates positively with ventilatory chemoresponsiveness. J Appl Physiol 1978;45:557-64.
18. Floras JS, Clinical aspects of sympathetic activation and parasympathetic withdrawal in heart failure. J Am Coll Cardiol 1993;22(Suppl A):72A-84A.
19. Cormack RS, Cunningham DJC. Gee JBL. The effect of carbon dioxide on the respiratory response to want of oxygen. Q J Exp Physiol 1957;42:323-34.
20. Weil JV, Byrne-Quinn E, Sodal IE, et al. Hypoxic ventilatory drive in normal man. J Clin Invest 1970;49:1061-72.
21. Rebuck AS, Campbell EJM. A clinical method for assessing the ventilatory response to hypoxia. Am Rev Respir Dis 1974;109:345-50.
22. Edelman NH, Lahiri S, Braudo L, Cherniack NS, Fishman AP. The blunted ventilatory response to hypoxia in cyanotic congenital heart disease. N Engl J Med 1970;282:405-11.
23. Kronenberg R, Hamilton FN, Gabel R, Hickey R, Read DJC, Severinghaus J. Comparison of three methods for quantitating respiratory response to hypoxia in man. Resp Physiol 1972;16:109.
24. Shaw RA, Schonfeld SA, Whitcomb M. Progressive and transient hypoxic ventilatory drive tests in healthy subjects. Am Rev Respir Dis 1982;126:37-40.
25. Edelman NH, Epstein PE, Lahiri S, Cherniack NS. Ventilatory responses to transient hypoxia and hypercapnia in man. Resp Physiol 1973;17:302-14.
26. Wasserman K, Hansen JE, Sue DY, Whipp BJ, Casaburi R. Principles of Exercise Testing and Interpretation. 2nd ed. Philadelphia: Lea & Febiger, 1994;52-79.
27. Sietsema KE, Ben-Dov I, Zhang YY, Sullivan C, Wasserman K. Dynamics of oxygen uptake for submaximal exercise and recovery in patients with chronic heart failure. Chest 1994;105:1693-700.
28. 2 as a clinical test of the peripheral chemoreflex. J Appl Physiol 1988;64:84-9.
29. Read DJC. A clinical method for assessing the ventilatory response to carbon dioxide. Australas Ann Med 1966;16:20-32.
30. 2. J Appl Physiol 1973:35: 903-13.
31. 2 chemoreflex drive of ventilation in man: effects of hyperoxia and sex difference. Respiration 1990;57:264-7.
32. Bruce RA, Blackman JR, Jones JW. Exercise testing in adult normal subjects and cardiac patients. Pediatrics 1963;32:742-55.
33. Davies N, Denison DM. The measurement of metabolic gas exchange and minute ventilation by mass spectrometry alone. Resp Physiol 1979;36:261-7.
34. Wilcox I, Grunstein RR, Collins FL, Berthon-Jones M, Kelly DT, Sullivan CE. The role of central chemosensitivity in central apnea of heart failure. Sleep 1993;16:837-8.
35. Hirshman CA, McCullough RE, Weil JV. Normal values for hypoxic and hypercapnic vcntilatory drives in man. J Appl Physiol 1975;38:1095-8.
36. Francis GS, Benedict C, Johnstone DE, et al. Comparison of neuroendocrine activation in patients with left ventricular dysfunction with and without congestive heart failure. Circulation 1990;82:1724-9.
37. Packer M. The neurohormonal hypothesis: a theory to explain the mechanism of disease progression in heart failure. J Am Coll Cardiol 1992;20:248-54.
38. Weil JV, Byrne-Quinn E, Sodal IE, Kline JS, McCullough RE, Filley GF. Augmentation of chemosensitivity during mild exercise in normal man. J Appl Physiol 1972;33:813-9.
39. 2 in man. Ann NY Acad Sci 1963;109:756-71.
40. Fidone SJ, Gonzalez C. Initiation and control of chemoreceptor activity in the carotid body. In: Cherniack NS. Widdicombe JG, eds. Handbook of Physiology, Section 3: The Respiratory System, Volume 2 - Control of Breathing. Bethesda: American Physiological Society, 1986:247-312.
41. Kao FF. An experimental study of the pathways involved in exercise hyperpnea employing cross-circulation techniques. In: Cunningham DJC, Lloyd BB, editors. The Regulation of Human Respiration. Oxford (UK): Blackwell, 1963:461-502.
42. Coats AJS, Clark AL, Piepoli M, Volterrani M, Poole-Wilson PA. Symptoms and quality of life in heart failure: the muscle hypothesis. Br Heart J 1994;72(Suppl):S36-9.
43. Piepoli M, Volterani M, Clark A, Sleight P, Poole-Wilson PA, Coats AJS. Training partially reverses abnormal skeletal muscle metaboreflex contribution to the vcntilatory drive in patients with chronic heart failure [abstract]. Eur Heart J 1995;16 Suppl:104.
44. Dempsey JA, Mitchell GS, Smith CA. Exercise and chemoreception. Am Rev Respir Dis 1984;129:31-4.
45. Dejours P. Control of respiration by arterial chemoreceptors. Ann NY Acad Sci 1963;109:682-95.
46. Weil JV, Swanson GD. Peripheral chemoreceptors and the control of breathing. In: Whipp BJ, Wasserman K, editors. Lung Biology in Health and Disease. Vol. 52, Exercise: Pulmonary Physiology and Pathophysiology. New York: Marcel Dekker, 1990;371-403.
47. Pandit JJ, Robbins PA. Acute ventilatory responses to hypoxia during voluntary and electrically induced leg exercise in man. J Physiol 1994;477: 161-8.
48. Paterson DJ. Potassium and ventilation in exercise. J Appl Physiol 1992;72: 811-20.
49. Purves MJ. Fluctuations of arterial oxygen tension which have the same period as respiration. Resp Physiol 1966;1:281-96.
50. 2 tension in a respiratory model: some implications for the control of breathing in exercise. J Theoret Biol 1980;84:163-79.
51. Sullivan MJ, Higginbotham MB, Cobb FR. Increased exercise ventilation in patients with chronic heart failure: intact ventilatory control despite hemo-dynamic and pulmonary abnormalities. Circulation 1988;77:552-9.
52. Clark AL, Coats AJS. Usefulness of arterial blood gas estimations during exercise in patients with chronic heart failure. Br Heart J 1994;71:528-30.
53. Moore DP, Weston AR, Hughes JMB, Oakley CM, Cleland JGF. Effects of increased oxygen concentrations on exercise performance in chronic heart failure. Lancet 1992;339:950-3.
54. Herrlin B, Sylven C. Increased arterial oxygen content - an important compensatory mechanism in chronic moderate heart failure. Cardiovascular Res 1991;25:384-90.
55. Woodcock AA, Gross ER, Gellert A, Shah S, Johnson M, Geddes DM. Effects of dihydrocodeine, alcohol and caffeine on breathlessness and exercise intolerance in patients with chronic obstructive lung disease and normal blood gases. N Engl J Med 1981;305:1611-6.
56. Hannhart B, Michalski H, Delorme N, Chapparo G, Polu J. Reliability of six pulse oximeters in chronic obstructive pulmonary disease. Chest 1991;99: 842-6.
57. Barker SJ, Hyatt J, Shah NK, Kao J. The effect of sensor malpositioning on pulse oximeter accuracy during hypoxemia. Anesthesiology 1993;79:248-54.